Cambridge-based organ-on-chip (OOC) technology developer CN Bio has established a strategic partnership with Japanese distributor Primetech Corporation to expand access to its microphysiological systems throughout Japan. The collaboration arrives as the Japanese OOC market demonstrates significant growth potential, with projections indicating a market value of £22.1M by 2030, representing a compound annual growth rate of […]

Finnish researchers have developed a high-throughput screening pipeline that enables simultaneous analysis of multiple drug responses in primary tumour samples at single-cell resolution, offering new possibilities for personalised cancer therapy.

Researchers at Linköping University have developed an improved version of the AI protein structure prediction tool AlphaFold, enabling analysis of larger protein complexes and integration of experimental data. The advancement marks a significant step forward in protein research and drug development.

Biotech firms VALANX Biotech and Fina Biosolutions have announced a collaborative agreement to commercialise ClickCRM, an engineered version of the carrier protein CRM197 designed to accelerate conjugate vaccine development. The partnership, announced on 29 October 2024, combines VALANX’s expertise in site-specific protein conjugation with FinaBio’s established presence in conjugate vaccine development.